AbbVie said contract pharmacies have used the law, Senate Bill 28, to “acquire manufacturers’ drugs at the federally discounted price, sell them to patients (including indigent patients) at full price, and pocket the difference.”
The two pharmaceutical companies challenged the constitutionality of the law and are seeking to nullify it.
